Index of reports
> Death (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Valtrex (Valacyclovir) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Valtrex side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female, weighing 3.2 kg (7.0 pounds)
Reactions: Death, Foetal Exposure During Pregnancy
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Valtrex
Other drugs received by patient: Flonase; Flexeril; Lyrica; Celebrex; Loratadine; Vitamin TAB; Relpax; Nexium; Glyburide; Topamax; Tramadol HCL; Chantix; Vicodin
Possible Valtrex side effects in female
Reported by a physician from United States on 2012-04-30
Patient: female, weighing 3.2 kg (7.0 pounds)
Reactions: Death, Foetal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Valtrex
Other drugs received by patient: Celebrex; Flonase; Relpax; Topamax; Tramadol HCL; Chantix; Vitamin TAB; Vicodin; Flexeril; Loratadine; Lyrica; Nexium
Possible Valtrex side effects in male
Reported by a physician from Switzerland on 2012-04-26
Patient: male
Reactions: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Coma Hepatic, Cholestasis, Hepatic Steatosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate Sodium
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Vfend
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Asparaginase
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Tazobactam
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Valtrex
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Other drugs received by patient: Navoban; Torsemide; Prednisone TAB; Bactrim
Possible Valtrex side effects in 68 year old male
Reported by a physician from Switzerland on 2012-04-24
Patient: 68 year old male
Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Tazobactam
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Cerubidine
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Oncovin
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cyclophosphamide
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Valtrex
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Asparaginase
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Vfend
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide
Possible Valtrex side effects in 68 year old male
Reported by a physician from Switzerland on 2012-02-10
Patient: 68 year old male
Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Valtrex
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Oncovin
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cerubidine
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Asparaginase
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Cyclophosphamide
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Tazobactam
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Vfend
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Prednisone; Torsemide; Bactrim; Navoban
Possible Valtrex side effects in male
Reported by a physician from Switzerland on 2012-02-08
Patient: male
Reactions: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Coma Hepatic, Cholestasis, Hepatic Steatosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Asparaginase
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Daunorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Vfend
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Methotrexate Sodium
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Tazobactam
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Valtrex
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Torsemide; Bactrim; Prednisone TAB; Navoban
Possible Valtrex side effects in female
Reported by a pharmacist from Japan on 2012-02-07
Patient: female, weighing 36.0 kg (79.2 pounds)
Reactions: PO2 Decreased, Dyspnoea, Blood Pressure Decreased, Shock, Feeling Cold
Adverse event resulted in: death
Drug(s) suspected as cause:
Valtrex
Other drugs received by patient: Cefazolin Sodium; Loxonin; Besacolin; Furosemide; Aspara K; Famotidine
Possible Valtrex side effects in female
Reported by a pharmacist from Japan on 2012-01-20
Patient: female, weighing 36.0 kg (79.2 pounds)
Reactions: PO2 Decreased, Dyspnoea, Blood Pressure Decreased, Feeling Cold, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Valtrex
Other drugs received by patient: Cefazolin Sodium; Aspara K; Loxonin; Famotidine; Besacolin; Furosemide
Possible Valtrex side effects in female
Reported by a physician from Japan on 2011-12-22
Patient: female
Reactions: Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Valganciclovir
Administration route: Oral
Start date: 2011-07-30
End date: 2011-08-08
Vancomycin Hychloride
Indication: Product Used FOR Unknown Indication
End date: 2011-09-05
Valganciclovir
Administration route: Oral
Indication: Cytomegalovirus Chorioretinitis
Start date: 2011-08-09
End date: 2011-08-22
Valganciclovir
Administration route: Oral
Start date: 2011-08-23
End date: 2011-08-29
Valganciclovir
Administration route: Oral
Start date: 2011-08-30
End date: 2011-09-02
Valtrex
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-23
End date: 2011-09-04
Other drugs received by patient: Silicone OIL; Zovirax; Funguard; Steroid EYE Drops; Fluconazole
|